跳至主要内容
临床试验/NCT05667870
NCT05667870招募中不适用

A Lifespan Perspective on Accelerated Aging in Congenital Heart Disease

KU Leuven2 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2023年2月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
KU Leuven
入组人数
1,200
试验地点
2
主要终点
Telomere length

研究概览

简要总结

Many childhood-onset diseases used to be lethal. Improved life expectancy yield that most patients can survive into adulthood, to date. However, survivors of childhood-onset diseases often develop morbidities that suggest accelerated aging. Indeed, age-related conditions are observed sooner and more frequently in people with childhood-onset diseases. Congenital heart disease (CHD) is a typical example of a childhood-onset disease and is the most common birth defect, comprising a spectrum of mild, moderate and complex heart defects. Recent studies showed that age-related morbidities occur more often and at an earlier age in these patients. The overall goal of this project is to quantify and understand disparities in chronological and biological age over the lifespan in CHD patients.

详细描述

Three main research objectives are proposed:

Objective 1: The investigators will determine the biological age in patients with CHD across the lifespan, using established and novel biomarkers for aging, and assess the disparity with chronological age.

Objective 2: The investigators will identify clinical, behavioral, psychological and social predictors of aging in patients with CHD.

Objective 3: The investigators will investigate the difference in biological-chronological age disparity between patients with CHD and healthy counterparts.

Three studies will be performed to investigate these objectives:

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Telomere length

时间窗: Baseline

Telomere length will be measured on umbilical cord blood from newborns and on peripheral blood from adults with and without CHD.

次要结局

  • Fall history as a functional outcome of aging in adults with CHD(Baseline)
  • Cognitive impairment as a functional outcome of aging in adults with CHD(Baseline)
  • Epigenetic clock in adults with and without CHD(Baseline)
  • Retina scan in adults with CHD(Baseline)
  • Clinical, behavioral, psychological and social predictors of telomere length(Baseline)
  • hsCRP in adults with CHD(Baseline)
  • Frailty as a functional outcome of aging in adults with CHD(Baseline)

研究者

发起方
KU Leuven
申办方类型
Other
责任方
Principal Investigator
主要研究者

Philip Moons

Prof. dr.

KU Leuven

研究点 (2)

Loading locations...

相似试验